🇺🇸 FDA
Patent

US 11970711

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

granted A61KA61K38/465A61K48/00

Quick answer

US patent 11970711 (Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription) held by The Regents of the University of California expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K38/465, A61K48/00, A61P, A61P31/00